
Professor @Pennmedicine We create #CellTherapy #Genetherapy - Tmunity (Kite) & Capstan (Abbvie) CoFounder, Past President @ISCTGlobal, @PNASNexus AE
Philadelphia, PA
Joined November 2010
- Tweets14.4K
- Following479
- Followers9.7K
- Likes6.2K
Replying to @BLLPHD
ποΈExcited to announce the website for Ring That Bell π which I co-wrote w internationally acclaimed Irish country music artist @mags__mccarthy. It tells the emotional story of a cancer patient facing relapse and the fierce advocacy, support, and groundbreaking science that offer new hope.
#cancer #cancerresearch #immunotherapy #hope
ringthatbellsong.com/
Bruce Levine, Ph.D. πΊπ¦π₯Όπ¬π§¬π§ͺπ retweeted
Most babies donβt receive a first measles vaccine until age 1. With measles endemic again, parents can no longer assume grocery stores, airports, churches, or even pediatriciansβ offices are safe spaces. The community protection we took for granted is gone, and U.S. moms now must live in fear that their babies will be harmed by a completely preventable disease, while they do every day tasks. π’
U.S. loses measles elimination status axios.com/2026/11/14/us-loseβ¦
Bruce Levine, Ph.D. πΊπ¦π₯Όπ¬π§¬π§ͺπ retweeted
EXCLUSIVE: The U.S. has lost its measles elimination status.
with @JenCalfas - free link: wsj.com/health/u-s-loses-meaβ¦
Pennsylvania confirms a seventh death tied to the nationβs worst measles outbreak in decades inquirer.com/health/pennsylvβ¦
EXCLUSIVE: The U.S. has lost its measles elimination status.
with @JenCalfas - free link: wsj.com/health/u-s-loses-meaβ¦
3
710
#geneediting >600 patients = Wow
$NTLA
"As of today, we have dosed more than 600 patients with our investigational in vivo gene editing therapies. We believe this is more than all other companies in the world combined.
We have up to six years of follow-up on some of these patients, and very importantly, we have yet to see any waning of pharmacodynamic or clinical effect."
βJohn Leonard President and CEO, during the HAE study update.
Bird Flu Death in Washington State Renews Concern Over the Virus - Remember those DOGE cuts of 25% of CDC staff and HHS leadership denigration of CDC expertise? Now (yesterday) would be a good time to have that expertise back in place nytimes.com/2026/11/05/healtβ¦
337
The Origin of Species (leukemia) at the cellular level
How does leukaemia develop? π©Έ How long does it take? β³
π Our paper, started back when I was a PhD student in @jrblundellβs lab, is out today in @Nature π
Yearly blood samples from women who developed AML in later life let us trace it back decades π
doi.org/10.1038/s41586-026-1β¦
Self-dealing, Graft, Grift, or Profiteering?
New: Members of a little-known but influential panel of experts picked by RFK Jr. to recommend which preventive services insurers must cover have major conflicts of interests and could stand to gain $$ from the decisions they make: statnews.com/2026/11/11/kennβ¦
389
Honoring veterans from βGulf to Goatβ
Last year, CAR T cell therapy pioneer Carl June completed a 1,200 mile bike ride and fundraiser for cancer research alongside his classmates, veterans from the Naval Academyβs Class of 1975 penntoday.upenn.edu/news/penβ¦
Patents issued this year are coming with this nifty cover page implying the USPTO was also founded in 1776. The first US Patent was actually granted on July 31, 1790, to Samuel Hopkins for a process of making potash and signed by George Washington. As of today, >12 million US patents have been issued.
GD2 is widely recognized as a target in neuroblastoma, but remains underappreciated in sarcoma.
Pleased to be a coauthor of this new study demonstrating that GD2 CAR T cells effectively kill Ewing sarcoma cells in 2D and 3D models, including cells with low GD2 expression, and infiltrate tumors and suppress growth in vivo. Led by @giugolli @massdomi & colleagues
#EwingsSarcoma (ES) is an aggressive cancer for which effective treatment options remain a significant unmet medical need.
π‘ This new @cddpress article supports the efficacy of GD2 CAR T cells against both in vitro models and a localized in vivo model of ES!
π go.nature.com/4AdWUNj
With GD2, reports of on target off tumor toxicity are of concern. Designing CARs against OAcGD2 may open an avenue for safer targeting of this solid tumor antigen.
biorxiv.org/content/10.64898β¦ Others are pursuing this angle as well.
4
227
The Misinformation Virus is killing paople
theguardian.com/technology/2β¦
1
598
Congratulations to @kiranmusunuru & @AhrensNicklas for not only pioneering individualized gene editing for Baby KJ, but also helping shape the regulatory pathway for the patients who will follow, with implications far beyond one patient or one disease.
The FDA's new draft guidance (in reply) is an important advance, recognizing that multiple patient-specific variants of a gene-editing therapy can be evaluated within a common regulatory framework, while maintaining rigorous standards for safety and efficacy.
This is how science and regulation should work together.inquirer.com/health/fda-guidβ¦
Individualized Human Genome Editing Products: Considerations for BLA Submission and Postapproval Management #FDA fda.gov/regulatory-informatiβ¦
2
195
Bruce Levine, Ph.D. πΊπ¦π₯Όπ¬π§¬π§ͺπ retweeted
If you ever needed the data to show what happens when vaccine disinformation spreads and trust in science is undermined - here it is.
Bruce Levine, Ph.D. πΊπ¦π₯Όπ¬π§¬π§ͺπ retweeted
We're reporting only a fraction of measles cases in the US; some estimates put it as low as 20% in states like PA. This outbreak is much larger than what's reported and is spilling into highly vulnerable communities like babies and pregnant women. We will lose our Measles elimination status this month, and it will take years of responsible public health management to get it back.
bloomberg.com/news/articles/β¦
America Votes, China Plans
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation @medicine_maker themedicinemaker.com/issues/β¦
1
429
βοΈ@medicine_maker China is pursuing a coordinated, long-term strategy to become a global leader in biopharmaceutical innovation, while the United States risks eroding its competitive advantage through unpredictable research funding, regulatory uncertainty, and fragmented policy.
1
1
300
The biotech China question @statnews The answer isn't isolation. It's investment in American science and innovation. We cannot afford to surrender leadership in the industries that will define the future of medicine. statnews.com/2026/05/18/biotβ¦
126



















